RAÚL J. ANDRADE BELLIDO – ENSAYO CLÍNICO CON MEDICAMENTOS – KOWA RESEARCH INSTITUTE INC.
A Phase 2, Multicenter, Placebo-Controlled, Randomized, Double-Blind, 48-Week Study to Evaluate the Efficacy and Safety of Combination Therapy of K-877-ER and CSG452 in Patients with Noncirrhotic Nonalcoholic Steatohepatitis (NASH) with Liver Fibrosis
por prodriguez | Jul 3, 2024 | Ensayos Clínicos, Ensayos Clínicos - D-05 | 0 Comentarios